Boehringer Ingelheim and Microsoft Develop Digital Twins in Clinical Research

The partnership aims to enhance clinical trial efficiency and patient outcomes.

Boehringer Ingelheim and Microsoft are collaborating to create digital twins in clinical research, a virtual replica of patients or trials to simulate and analyze data.

This approach can help researchers identify potential issues and optimize trial design, reducing costs and improving patient outcomes.

The companies plan to apply their work in various therapeutic areas, including oncology and cardiovascular diseases.